Live Quote · NASDAQNVIVHealthcare· Biotechnology

InVivo Therapeutics Holdings Corporation

$0.32 34.28%($-0.17)
TickerSpark Score
58/100
Mixed
100
Valuation
25
Profitability
50
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVIV research report →

52-Week Range5% of range
Low
$0.22
Current
$0.32
High
$2.40

About the company

InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI).

CEO
Richard M. Toselli
IPO
2010
Employees
6
HQ
Cambridge, MA, US

Price Chart

-73.74% · this period
$1.47$0.85$0.22Mar 10Sep 11Mar 11
Valuation
Market Cap
$995.92K
P/E
-0.05
P/S
0.00
P/B
0.03
EV/EBITDA
1.46
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-60.12%
ROIC
-63.58%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-10,179,000 · -2.90%
EPS
$-6.62 · 11.38%
Op Income
$-10,650,000
FCF YoY
-19.16%
Performance & Tape
52W High
$2.40
52W Low
$0.22
50D MA
$0.70
200D MA
$1.05
Beta
0.66
Avg Volume
3.77M

Get TickerSpark's AI analysis on NVIV

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Feb 5, 23Foose Bricesell37,000
Feb 5, 23Foose Bricesell20,000
Feb 5, 23Foose Bricesell13,000
Feb 5, 23Foose Bricesell48,000
Feb 5, 23Foose Bricesell12,000
Feb 5, 23Foose Bricesell36,000
Feb 6, 23Foose Bricesell8,000
Feb 6, 23Foose Bricesell33,000
Feb 6, 23Foose Bricesell35,000
Feb 6, 23Foose Bricesell37,000
Coverage · NVIV

Our NVIV coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on NVIV yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate NVIV report →
Internal Compare

Similar companies

Peers in the same neighborhood.